N-(4-(N-(2-amino-2-oxoethyl)-N-(4-(N-(2-amino-2-oxoethyl)-4-methoxyphenylsulfonamido)naphthalen-1-yl)sulfamoyl)phenyl)-3-(4-isopropylpiperazin-1-yl)propanamide

ID: ALA5206662

Chembl Id: CHEMBL5206662

PubChem CID: 168294269

Max Phase: Preclinical

Molecular Formula: C37H45N7O8S2

Molecular Weight: 779.94

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)N(CC(N)=O)c2ccc(N(CC(N)=O)S(=O)(=O)c3ccc(NC(=O)CCN4CCN(C(C)C)CC4)cc3)c3ccccc23)cc1

Standard InChI:  InChI=1S/C37H45N7O8S2/c1-26(2)42-22-20-41(21-23-42)19-18-37(47)40-27-8-12-29(13-9-27)53(48,49)43(24-35(38)45)33-16-17-34(32-7-5-4-6-31(32)33)44(25-36(39)46)54(50,51)30-14-10-28(52-3)11-15-30/h4-17,26H,18-25H2,1-3H3,(H2,38,45)(H2,39,46)(H,40,47)

Standard InChI Key:  RLXZLIPXEZYRSP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5206662

    ---

Associated Targets(Human)

NFE2L2 Tchem Keap1/Nrf2 (1722 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Peritoneal macrophage (1554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 779.94Molecular Weight (Monoisotopic): 779.2771AlogP: 2.56#Rotatable Bonds: 16
Polar Surface Area: 205.75Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.17CX Basic pKa: 8.42CX LogP: 1.56CX LogD: 0.41
Aromatic Rings: 4Heavy Atoms: 54QED Weighted: 0.15Np Likeness Score: -1.30

References

1. Liu G, Hou R, Xu L, Zhang X, Yan J, Xing C, Xu K, Zhuang C..  (2022)  Crystallography-Guided Optimizations of the Keap1-Nrf2 Inhibitors on the Solvent Exposed Region: From Symmetric to Asymmetric Naphthalenesulfonamides.,  65  (12.0): [PMID:35687391] [10.1021/acs.jmedchem.2c00170]

Source